Laddar...
A Fracture Does Not Adversely Affect Bone Mineral Density Responses after Teriparatide Treatment
BACKGROUND: Fracture leads to local and systemic catabolic physiologic changes. As teriparatide is an agent used to treat osteoporosis in patients with fragility fractures, it is unclear whether teriparatide treatment alters bone mineral density (BMD) and bone markers when given to patients with fra...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer-Verlag
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3270178/ https://ncbi.nlm.nih.gov/pubmed/21863393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-011-2029-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|